600+ sources. One page. See who else covered it.
The FDA is “willing to review” an updated submission for Capricor’s Duchenne cell therapy, its CEO said. Elsewhere, a heart drug battle spilled into court and Rigel priced the first “Protac” medicine.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
The Ebola virus is spreading rapidly in the DRC. In Kinshasa, a city of millions, fears of a serious health crisis are growing. Hospitals are scrambling to prepare for emergencies as best as they can.
The Ebola virus is spreading rapidly in the DRC. In Kinshasa, a city of millions, fears of a serious health crisis are growing. Hospitals are scrambling to prepare for emergencies as best as they can.
Respondents were split on who should solve the issues, with Democrats more likely to say the federal government and Republicans more likely to name insurers, according to a survey from the…
(MedPage Today) -- Note that some links may require registration or subscription. Chintan Shah, MD, an assistant professor at the University of Florida facing child porn charges, was found dead in his…
People who have survived sepsis don't respond to vaccines in the same way as those who haven't had sepsis, according to new clinical trial results.
